Health Care & Life Sciences » Medical Equipment & Supplies | Biostage Inc.

Biostage Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
22.00
93.00
118.00
82.00
-
261
Cost of Goods Sold (COGS) incl. D&A
158.00
411.00
617.00
570.00
413.00
261
Gross Income
136.00
318.00
499.00
488.00
413.00
261
SG&A Expense
8,681.00
10,739.00
11,202.00
11,638.00
11,055.00
7,580
EBIT
8,817.00
11,057.00
11,701.00
12,126.00
11,468.00
7,841
Unusual Expense
-
-
-
547.00
337.00
82
Non Operating Income/Expense
-
4.00
3.00
-
111.00
7
Pretax Income
8,817.00
11,061.00
11,704.00
11,579.00
11,916.00
7,529
Consolidated Net Income
8,817.00
11,061.00
11,704.00
11,579.00
11,916.00
7,529
Net Income
8,817.00
11,061.00
11,704.00
11,579.00
11,916.00
7,529
Net Income After Extraordinaries
8,817.00
11,061.00
11,704.00
11,579.00
11,916.00
7,529
Net Income Available to Common
8,817.00
11,061.00
11,704.00
11,579.00
11,916.00
7,529
EPS (Basic)
22.78
28.29
21.00
14.60
6.63
1.69
Basic Shares Outstanding
387.00
391.10
557.70
798.60
1,797.00
4,463
EPS (Diluted)
22.78
28.29
20.99
14.50
6.63
1.69
Diluted Shares Outstanding
387.00
391.10
557.70
798.60
1,797.00
4,463
EBITDA
8,659.00
10,694.00
11,223.00
11,672.00
11,055.00
7,580

About Biostage

View Profile
Address
84 October Hill Road
Holliston Massachusetts 01746
United States
Employees -
Website http://www.biostage.com
Updated 07/08/2019
Biostage, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. The company was founded on May 3, 2012 and is headquartered in Holliston, MA.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.